These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32592507)

  • 1. Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
    Stoian AP; Catrinoiu D; Rizzo M; Ceriello A
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3379. PubMed ID: 32592507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the interaction between COVID-19 and diabetes mellitus.
    Chee YJ; Tan SK; Yeoh E
    J Diabetes Investig; 2020 Sep; 11(5):1104-1114. PubMed ID: 32558211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.
    Rayman G; Lumb AN; Kennon B; Cottrell C; Nagi D; Page E; Voigt D; Courtney HC; Atkins H; Higgins K; Platts J; Dhatariya K; Patel M; Newland-Jones P; Narendran P; Kar P; Burr O; Thomas S; Stewart R
    Diabet Med; 2021 Jan; 38(1):e14378. PubMed ID: 32740972
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors Affecting the Incidence, Progression, and Severity of COVID-19 in Type 1 Diabetes Mellitus.
    Ahmed AS; Alotaibi WS; Aldubayan MA; Alhowail AH; Al-Najjar AH; Chigurupati S; Elgharabawy RM
    Biomed Res Int; 2021; 2021():1676914. PubMed ID: 34840966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.
    Infante M; Ricordi C; Fabbri A
    J Diabetes; 2020 Sep; 12(9):659-667. PubMed ID: 32401405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection-related diabetes mellitus.
    Beliard K; Wilkes M; Yau M; Aluf A; Rapaport R
    J Diabetes; 2021 Jun; 13(6):523-524. PubMed ID: 33660918
    [No Abstract]   [Full Text] [Related]  

  • 8. Chloroquine in fighting COVID-19: good, bad, or both?
    Tang D; Li J; Zhang R; Kang R; Klionsky DJ
    Autophagy; 2020 Dec; 16(12):2273-2275. PubMed ID: 32713288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19.
    In 't Veld AE; Jansen MAA; Ciere LCA; Moerland M
    J Immunol Res; 2021; 2021():6659410. PubMed ID: 33763494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues for the management of people with diabetes and COVID-19 in ICU.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Cardiovasc Diabetol; 2020 Jul; 19(1):114. PubMed ID: 32690029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of COVID-19 on people with diabetes.
    Bellido V; Pérez A
    Endocrinol Diabetes Nutr (Engl Ed); 2020; 67(6):355-356. PubMed ID: 32475769
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
    Liu Y; Fu X; Xie C
    Medicine (Baltimore); 2020 Sep; 99(37):e22031. PubMed ID: 32925737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
    Ceriello A; Schnell O
    J Diabetes Sci Technol; 2020 Jul; 14(4):723-724. PubMed ID: 32475168
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes Mellitus and COVID-19: Review Article.
    Nassar M; Daoud A; Nso N; Medina L; Ghernautan V; Bhangoo H; Nyein A; Mohamed M; Alqassieh A; Soliman K; Alfishawy M; Sachmechi I; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102268. PubMed ID: 34562865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism.
    Perrella A; Orlando V; Trama U; Bernardi FF; Menditto E; Coscioni E
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.
    Sun B; Luo Z; Zhou J
    Cardiovasc Diabetol; 2021 Jan; 20(1):9. PubMed ID: 33413392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
    Mori N; Katayama M; Nukaga S
    J Microbiol Immunol Infect; 2021 Feb; 54(1):109-112. PubMed ID: 33054978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and COVID-19: A review and management guidance for South Africa.
    Coetzee A; Taljaard JJ; Hugo SS; Conradie M; Conradie-Smit M; Dave JA
    S Afr Med J; 2020 Jun; 110(8):761-766. PubMed ID: 32880304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes, obesity and COVID-19: A complex interplay.
    Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
    Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India.
    Khare J; Jindal S
    Diabetes Metab Syndr; 2020; 14(6):1571-1574. PubMed ID: 32858474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.